EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Potential of Probiotics in Reducing Ventilator-Associated Pneumonia: A Literature-Based Analysis

Tao-An Chen iD, Ya-Ting Chuang, Szu-Chi Pai, Jin-Fu Zheng

Microorganisms · 09.04.2025 · 13 (4) · 856

DOI: 10.3390/microorganisms13040856 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 09.04.2025. Verfasst von Tao-An Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Therapy, Department of Chest Medicine, Show Chwan Memorial Hospital, Changhua 500, Taiwan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ventilator-associated pneumonia (VAP) remains a significant concern in intensive care units (ICUs), contributing to increased morbidity, mortality, and healthcare costs. Probiotics and synbiotics have been explored as potential preventive measures due to their ability to modulate gut microbiota, reduce pathogenic colonization, enhance immune responses, and maintain intestinal barrier integrity. While some randomized controlled trials (RCTs) suggest that specific strains, such as Lactobacillus rhamnosus GG and Bifidobacterium breve, may reduce VAP incidence, larger trials have not confirmed significant benefits. Systematic reviews and meta-analyses indicate a potential 28–38% relative risk reduction in VAP, but evidence quality remains low due to methodological limitations and study heterogeneity. Economic evaluations also question the cost effectiveness of probiotic use in ICU settings. Future research should focus on large-scale, multicenter RCTs to determine the optimal strains, dosages, and administration methods, along with standardized diagnostic criteria. Until stronger evidence emerges, probiotics should be considered an adjunctive rather than a primary VAP prevention strategy.

Schlagwörter

Stichwörter der Autor:innen

cost effectiveintensive care unitmicrobiota modulationprobioticsrandomized controlled trialssynbioticssystematic reviewsventilator-associated pneumonia

Autor:innen und Institutionen

  • Division of Respiratory Therapy, Department of Chest Medicine, Show Chwan Memorial Hospital, Changhua 500, Taiwan.
  • Surgical Intensive Care Unit, Show Chwan Memorial Hospital, Changhua 500, Taiwan.
  • Department of Gastroenterology Medicine, Show Chwan Memorial Hospital, Changhua 500, Taiwan.

ORCID-Profile: Tao-An Chen

Zitieren

APA

Chen, T. A., Chuang, Y. T., Pai, S. C., & Zheng, J. F. (2025). The Potential of Probiotics in Reducing Ventilator-Associated Pneumonia: A Literature-Based Analysis. Microorganisms, 13(4), 856. https://doi.org/10.3390/microorganisms13040856

Vancouver

Chen TA, Chuang YT, Pai SC, Zheng JF. The Potential of Probiotics in Reducing Ventilator-Associated Pneumonia: A Literature-Based Analysis. Microorganisms. 2025;13(4):856. doi:10.3390/microorganisms13040856

BibTeX
@article{Chen2025,
  author = {Chen, Tao-An and Chuang, Ya-Ting and Pai, Szu-Chi and Zheng, Jin-Fu},
  title = {The Potential of Probiotics in Reducing Ventilator-Associated Pneumonia: A Literature-Based Analysis},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {4},
  pages = {856},
  doi = {10.3390/microorganisms13040856}
}
Kostenlos starten →